Identification of residues of the moloney murine leukemia virus nucleocapsid critical for viral DNA synthesis in vivo

Journal of Virology

Volumn 75, Issue 6, 2001, Pages 2616-2626

  Gonsky, J ^a   Bacharach, E ^a   Goff, S P ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GAG PROTEIN; NUCLEIC ACID BINDING PROTEIN; PRIMER RNA; SPLICED LEADER RNA; TRANSFER RNA; VIRUS DNA; VIRUS PROTEIN; VIRUS RNA;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA SYNTHESIS; MOLONEY LEUKEMIA ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION; RNA GENE; VIRUS ASSEMBLY; VIRUS GENOME; VIRUS MUTANT; VIRUS MUTATION; VIRUS NUCLEOCAPSID; VIRUS PARTICLE; VIRUS REPLICATION;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; CELL LINE; DNA, VIRAL; GENE PRODUCTS, GAG; MICE; MOLECULAR SEQUENCE DATA; MOLONEY MURINE LEUKEMIA VIRUS; MUTATION; NUCLEOCAPSID PROTEINS; TRANSCRIPTION, GENETIC; TRANSFECTION; VIRION; VIRUS REPLICATION;

EID: 0035127602     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.6.2616-2626.2001     Document Type: Article

References (67)

1. Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus
2. Amino acid substitutions in the CA protein of Moloney murine leukemia virus that block early events in infection
3. Mutational analysis of interactions between the Gag precursor proteins of murine leukemia viruses
4. Binding of the human immunodeficiency virus type I Gag protein to the viral RNA encapsidation signal in the yeast three-hybrid system
5. RNA packaging
6. Specific binding of human immunodeficiency virus type 1 Gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays
7. Retroviral nucleocapsid domains mediate the specific recognition of genomic viral RNAs by chimeric Gag polyproteins during RNA packaging in vivo
8. Mutations in the N-terminal domain of human immunodeficiency virus type 1 nucleocapsid protein affect virion core structure and proviral DNA synthesis
9. Importance of basic residues in the nucleocapsid sequence for retrovirus Gag assembly and complementation rescue
10. Human immunodeficiency virus type 1 Gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsiddimer interface and the basic region of matrix protein
11. Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA
12. Sequence and spacing requirements of a retrovirus integration site
13. Mutations in Gag proteins P12 and P15 of Moloney murine leukemia virus block early stages of infection
14. Specific binding of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues
15. Cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1
16. Low-molecular-weight Rauscher leukemia virus protein with preferential binding for single-stranded RNA and DNA
17. The role of nucleocapsid of HIV-1 in virus assembly
18. Structure of the HIV-1 nucleocapsid protein bound to the SL3 psi-RNA recognition element
19. Two short basic sequences surrounding the zinc finger of nucleocapsid protein NCp10 of Moloney routine leukemia virus are critical for RNA annealing activity
20. Viral RNA annealing activities of human immuno-deficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers
21. Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein
22. Evidence of interactions between the nucleocapsid protein NCp7 and the reverse transcriptase of HIV-1
23. Point mutations in the proximal Cys-His box of Rous sarcoma virus nucleocapsid protein
24. HIV-1 nucleocapsid protein induces "maturation" of dimeric retroviral RNA in vitro
25. Specificity and sequence requirements for interactions between various retroviral Gag proteins
26. Characterization of human immunodeficiency virus type I dimeric RNA from wild-type and protease-defective virions
27. Maturation of dimeric viral RNA of Moloney murine leukemia virus
28. Replication defect of Moloney murine leukemia virus with a mutant reverse transcriptase that can incorporate ribonucleotides and deoxyribonucleotides
29. Genetic analysis of the zinc finger in the Moloney murine leukemia virus nucleocapsid domain: Replacement of zinc-coordinating residues with other zinc-coordinating residues yields noninfectious particles containing genomic RNA
30. Characterization of the block in replication of nucleocapsid protein zinc finger mutants from Moloney murine leukemia virus
31. Point mutants of Moloney murine leukemia virus that fail to package viral RNA: Evidence for specific RNA recognition by a "zinc finger-like" protein sequence
32. Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA
33. Human immunodeficiency virus type 1 nucleocapsid protein promotes efficient strand transfer and specific viral DNA synthesis by inhibiting TAR-dependent self-priming from minus-strand strong-stop DNA
34. Selective extraction of polyoma DNA from infected mouse cell cultures
35. Basic amino acids flanking the zinc finger of Moloney murine leukemia virus nucleocapsid protein NCp10 are critical for virus infectivity
36. Involvement of HIV-1 nucleocapsid protein in the recruitment of reverse transcriptase into nucleoprotein complexes formed in vitro
37. Foamy viruses are unconventional retroviruses
38. Binding of human immunodeficiency virus type 1 (HIV-1) RNA to recombinant HIV-1 Gag polyprotein
39. Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis
40. Characterization of Moloney murine leukemia virus mutants with single-amino-acid substitutions in the Cys-His box of the nucleocapsid protein
41. Mutations in Rous sarcoma virus nucleocapsid protein p12 (NC): Deletions of Cys-His boxes
42. Role of the Gag polyprotein precursor in packaging and maturation of Rous sarcoma virus genomic RNA
43. Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins
44. Production of high-titer helper-free retroviruses by transient transfection
45. Charged amino acid residues of human immunodeficiency virus type 1 nucleocapsid p7 protein involved in RNA packaging and infectivity
46. Viral RNA annealing activities of the nucleocapsid protein of Moloney murine leukemia virus are zinc independent
47. Small finger protein of avian and murine retroviruses has nucleic acid annealing activity and positions the replication primer tRNA onto genomic RNA
48. The role of Gag in human immunodeficiency virus type 1 virion morphogenesis and early steps of the viral life cycle
49. Evidence that a central domain of nucleocapsid protein is required for RNA packaging in murine leukemia virus
50. Nucleic-acid-chaperone activity of retroviral nucleocapsid proteins: Significance for viral replication
51. The annealing of tRNA3Lys to human immunodeficiency virus type 1 primer binding site is critically dependent on the NCp7 zinc fingers structure
52. Roles of the human immunodeficiency virus type 1 nucleocapsid protein in annealing and initiation versus elongation in reverse transcription of viral negative-strand strong-stop DNA
53. Mutations of basic amino acids of NCp7 of human immunodeficiency virus type I affect RNA binding in vitro
54. NMR structure of the complex between the zinc finger protein NCp10 of Moloney murine leukemia virus and the single-stranded pentanucleotide d(ACGCC): Comparison with HIV-NCp7 complexes
55. Mutations in the gag gene of Moloney murine leukemia virus: Effects on production of virions and reverse transcriptase
56. The nucleocapsid protein isolated from HIV-1 particles binds zinc and forms retroviral-type zinc fingers
57. Mutational analysis of the major homology region of Mason-Pfizer monkey virus by use of saturation mutagenesis
58. Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution-state structure of the nucleocapsid protein from HIV-1
59. Assays for retroviral reverse transcriptase
60. Form, function, and use of retroviral gag proteins
61. Human immunodeficiency virus type 1 nucleocapsid protein reduces reverse transcriptase pausing at a secondary structure near the murine leukemia virus polypurine tract
62. Human immunodeficiency virus nucleocapsid protein accelerates strand transfer of the terminally redundant sequences involved in reverse transcription
63. The zinc finger of nucleocapsid protein of Friend murine leukemia virus is critical for proviral DNA synthesis in vivo
64. Effects of nucleocapsid mutations on human immunodeficiency virus assembly and RNA encapsidation
65. Nucleocapsid protein effects on the specificity of retrovirus RNA encapsidation
66. Analysis of the assembly function of the human immunodefieieney virus type 1 Gag protein nueleocapsid domain